Cooper Companies profit margin COO
Gross, operating and net profit as a share of revenue over the last twelve months, from 2010.
- Net margin, 12 months
- 13.5%
- Operating margin, 12 months
- 12.8%
- Net margin on a year earlier
- +3.4 pts
- Peer median
- 11.8%
Over the twelve months to Jul 31, 2026, Cooper Companies kept 13.5% of its revenue as net profit, with an operating margin of 12.8% and a gross margin of 65.9%.
The median for 10 medical instruments and supplies stocks of a similar size is 11.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 9.2% | 16.7% | 65.5% |
| FY2024 | 10.1% | 18.1% | 66.6% |
| FY2023 | 8.2% | 14.8% | 65.6% |
| FY2022 | 11.7% | 15.3% | 64.7% |
| FY2021 | n/a | 17.3% | 66.9% |
| FY2020 | 9.8% | 12.8% | 63.1% |
| FY2019 | 17.6% | 20.6% | 66.2% |
| FY2018 | 5.5% | 15.9% | 64.4% |
| FY2017 | 17.4% | 20.1% | 63.9% |
| FY2016 | 13.9% | 16.5% | 59.6% |
| FY2015 | 11.3% | 13.2% | 59.6% |
| FY2014 | 15.7% | 17.8% | 63.5% |
| FY2013 | 18.7% | 19.3% | 64.7% |
| FY2012 | 17.2% | 19.6% | 63.9% |
| FY2011 | 13.2% | 17.1% | 60.5% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q3 FY26 | 13.5% | +3.4 pts | 12.8% | |
| Q2 FY26 | 5.6% | −4.8 pts | 11.8% | |
| Q1 FY26 | 9.7% | −0.9 pts | 17.2% | |
| Q4 FY25 | 9.2% | −0.9 pts | 16.7% | |
| Q3 FY25 | 10.1% | +0.6 pts | 18.3% | |
| Q2 FY25 | 10.4% | +1.3 pts | 19.0% | |
| Q1 FY25 | 10.6% | +2.6 pts | 18.7% | |
| Q4 FY24 | 10.1% | +1.9 pts | 18.1% | |
| Q3 FY24 | 9.4% | +1.6 pts | 16.9% | |
| Q2 FY24 | 9.1% | +0.7 pts | 16.1% | |
| Q1 FY24 | 7.9% | −3.2 pts | 14.6% | |
| Q4 FY23 | 8.2% | −3.5 pts | 14.8% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Cooper Companies' size, closest first, today.
| Company | Profit margin |
|---|---|
| COOCooper Companies | 13.5% |
| ALGNAlign Technology | 10.0% |
| GMEDGlobus Medical | 17.0% |
| PENPenumbra | 10.7% |
| PODDInsulet | 12.3% |
| SOLVSolventum | 17.3% |
| MSAMSA Safety | 16.1% |
| MMSIMerit Medical Systems | 9.2% |
| HAEHaemonetics | 7.1% |
| WSTWest Pharmaceutical Services | 17.0% |
| VNTVontier | 11.3% |
| Peer median | 11.8% |
Where Cooper Companies ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Cooper Companies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.